FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053369535> ?p ?o ?g. }

• W2053369535 endingPage "e33684" @default.
• W2053369535 startingPage "e33684" @default.
• W2053369535 abstract "Introduction Pre-temozolomide studies demonstrated that loss of the tumor suppressor gene PTEN held independent prognostic significance in GBM patients. We investigated whether loss of PTEN predicted shorter survival in the temozolomide era. The role of PTEN in the PI3K/Akt pathway is also reviewed. Methods Patients with histologically proven newly diagnosed GBM were identified from a retrospective database between 2007 and 2010. Cox proportional hazards analysis was used to calculate the independent effects of PTEN expression, age, extent of resection, Karnofsky performance scale (KPS), and treatment on overall survival. Results Sixty-five percent of patients were men with median age of 63 years, and 70% had KPS≥80. Most patients (81%) received standard treatment (temozolomide with concurrent radiation). A total of 72 (47%) patients had retained PTEN expression. Median overall survival (OS) was 19.1 months (95% CI: 15.0–22.5). Median survival of 20.0 months (95% CI: 15.0–25.5) and 18.2 months (95% CI: 13.0–25.7) was observed in PTEN retained and PTEN loss patients, respectively (p = .71). PTEN loss patients were also found to have amplifications of EGFR gene more frequently than patients with retained PTEN (70.8% vs. 47.8%, p = .01). Multivariate analysis showed that older age (HR 1.64, CI: 1.02–2.63, p = .04), low KPS (HR 3.57, CI: 2.20–5.79, p<.0001), and lack of standard treatment (HR 3.98, CI: 2.38–6.65, p<.0001) yielded worse survival. PTEN loss was not prognostic of overall survival (HR 1.31, CI: 0.85–2.03, p = .22). Conclusions Loss of expression of PTEN does not confer poor overall survival in the temozolomide era. These findings imply a complex and non-linear molecular relationship between PTEN, its regulators and effectors in the tumorigenesis of glioblastoma. Additionally, there is evidence that temozolomide may be more effective in eradicating GBM cancer cells with PTEN loss and hence, level the outcomes between the PTEN retained and loss groups." @default.
• W2053369535 created "2016-06-24" @default.
• W2053369535 creator A5006853372 @default.
• W2053369535 creator A5009418577 @default.
• W2053369535 creator A5010077225 @default.
• W2053369535 creator A5016185028 @default.
• W2053369535 creator A5019253871 @default.
• W2053369535 creator A5030810684 @default.
• W2053369535 creator A5033380881 @default.
• W2053369535 creator A5041129985 @default.
• W2053369535 creator A5048403260 @default.
• W2053369535 creator A5064689690 @default.
• W2053369535 creator A5073387528 @default.
• W2053369535 date "2012-03-29" @default.
• W2053369535 modified "2023-10-13" @default.
• W2053369535 title "Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era" @default.
• W2053369535 cites W1922426509 @default.
• W2053369535 cites W1971865179 @default.
• W2053369535 cites W1979012323 @default.
• W2053369535 cites W1985453548 @default.
• W2053369535 cites W1990332775 @default.
• W2053369535 cites W1992772472 @default.
• W2053369535 cites W1996484632 @default.
• W2053369535 cites W2001660159 @default.
• W2053369535 cites W2009972187 @default.
• W2053369535 cites W2010677999 @default.
• W2053369535 cites W2031968704 @default.
• W2053369535 cites W2035008060 @default.
• W2053369535 cites W2036677238 @default.
• W2053369535 cites W2039872271 @default.
• W2053369535 cites W2048910214 @default.
• W2053369535 cites W2053521827 @default.
• W2053369535 cites W2055475004 @default.
• W2053369535 cites W2068345721 @default.
• W2053369535 cites W2068427129 @default.
• W2053369535 cites W2070705072 @default.
• W2053369535 cites W2079537922 @default.
• W2053369535 cites W2081994535 @default.
• W2053369535 cites W2084469720 @default.
• W2053369535 cites W2093833764 @default.
• W2053369535 cites W2096287682 @default.
• W2053369535 cites W2102353246 @default.
• W2053369535 cites W2106893529 @default.
• W2053369535 cites W2107406789 @default.
• W2053369535 cites W2111125738 @default.
• W2053369535 cites W2111309453 @default.
• W2053369535 cites W2121625674 @default.
• W2053369535 cites W2121749405 @default.
• W2053369535 cites W2141055671 @default.
• W2053369535 cites W2143004704 @default.
• W2053369535 cites W2143739956 @default.
• W2053369535 cites W2147114673 @default.
• W2053369535 cites W2154692501 @default.
• W2053369535 cites W2161289668 @default.
• W2053369535 cites W2161810908 @default.
• W2053369535 cites W2316848840 @default.
• W2053369535 cites W2316897574 @default.
• W2053369535 cites W4244279664 @default.
• W2053369535 cites W4255289481 @default.
• W2053369535 doi "https://doi.org/10.1371/journal.pone.0033684" @default.
• W2053369535 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3315579" @default.
• W2053369535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22479427" @default.
• W2053369535 hasPublicationYear "2012" @default.
• W2053369535 type Work @default.
• W2053369535 sameAs 2053369535 @default.
• W2053369535 citedByCount "61" @default.
• W2053369535 countsByYear W20533695352012 @default.
• W2053369535 countsByYear W20533695352013 @default.
• W2053369535 countsByYear W20533695352014 @default.
• W2053369535 countsByYear W20533695352015 @default.
• W2053369535 countsByYear W20533695352016 @default.
• W2053369535 countsByYear W20533695352017 @default.
• W2053369535 countsByYear W20533695352018 @default.
• W2053369535 countsByYear W20533695352019 @default.
• W2053369535 countsByYear W20533695352020 @default.
• W2053369535 countsByYear W20533695352021 @default.
• W2053369535 countsByYear W20533695352022 @default.
• W2053369535 countsByYear W20533695352023 @default.
• W2053369535 crossrefType "journal-article" @default.
• W2053369535 hasAuthorship W2053369535A5006853372 @default.
• W2053369535 hasAuthorship W2053369535A5009418577 @default.
• W2053369535 hasAuthorship W2053369535A5010077225 @default.
• W2053369535 hasAuthorship W2053369535A5016185028 @default.
• W2053369535 hasAuthorship W2053369535A5019253871 @default.
• W2053369535 hasAuthorship W2053369535A5030810684 @default.
• W2053369535 hasAuthorship W2053369535A5033380881 @default.
• W2053369535 hasAuthorship W2053369535A5041129985 @default.
• W2053369535 hasAuthorship W2053369535A5048403260 @default.
• W2053369535 hasAuthorship W2053369535A5064689690 @default.
• W2053369535 hasAuthorship W2053369535A5073387528 @default.
• W2053369535 hasBestOaLocation W20533695351 @default.
• W2053369535 hasConcept C10515644 @default.
• W2053369535 hasConcept C126322002 @default.
• W2053369535 hasConcept C143998085 @default.
• W2053369535 hasConcept C167135981 @default.
• W2053369535 hasConcept C190283241 @default.
• W2053369535 hasConcept C2777389519 @default.
• W2053369535 hasConcept C2777609662 @default.

• next